GRL0617, CAS 1093070-16-6

Product Description: GRL0617 is a selective and competitive noncovalent inhibitor of severe acute respiratory syndrome (SARS-CoV) papain-like protease (PLpro), with an IC50 of 0.6 μM and a Ki value of 0.49 μM. GRL0617 also inhibits SARS-CoV with an EC50 of 14.5 μM. GRL0617 can be used for the research of severe acute respiratory syndrome[1].

Applications: COVID-19-anti-virus

Formula: C20H20N2O

References: [1]Ratia K, et al. A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication. Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16119-24.

CAS Number: 1093070-16-6

Molecular Weight: 304.39

Compound Purity: 99.62

Research Area: Infection

Solubility: DMSO : 125 mg/mL (ultrasonic)

Target: Deubiquitinase;SARS-CoV

• Artikelnummer: MEXHY-117043-10.1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-117043-10.1
• Verpackungseinheit: 10 mM/1 ml
• Mengeneinheit: STK